References
- Ahn SJ, Kahn D, Zhou S, et al (2005). Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys, 61, 335-47. https://doi.org/10.1016/j.ijrobp.2004.06.014
- Bradley J, Deasy JO, Bentzen S, Naqa IE (2004). Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys, 58, 1106-13. https://doi.org/10.1016/j.ijrobp.2003.09.080
- Caglar HB, Othus M, Allen AM (2010). Esophagus in- field: a new predictor for esophagitis. Radiother Oncol, 97, 48-53. https://doi.org/10.1016/j.radonc.2010.07.024
- Court L, Wang J, Lin S (2012). SU-E-T-250:Dose-Response curves for the esophagus. Med Phys, 39, 3761.
- De Ruysscher D, Van Meerbeeck J, Vandecasteele K, et al (2012). Radiation-induced oesophagitis in lung cancer Patients : Is susceptibility for neutropenia a risk factor? Strahlenther Onkol, 188, 564-7. https://doi.org/10.1007/s00066-012-0098-z
- Dorr W, Hendry JH (2001). Consequential late effects in normal tissues. Radiother Oncol, 61, 223-31. https://doi.org/10.1016/S0167-8140(01)00429-7
- Emami B, Lyman J, Brown A et al (1991). Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 21, 109-22.
- Hirota S, Tsujino K, Hishikawa Y, et al (2001). Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies. Radiother Oncol, 58, 273-8. https://doi.org/10.1016/S0167-8140(00)00274-7
- Huang EX, Bradley JD, Naga IE, et al (2012). Modeling the risk of radiation-Induced acute esophagitis for combined Washington University and RTOG Trial 93-11 lung cancer patients. Int J Radiat Oncol Biol Phys, 82, 1674-9. https://doi.org/10.1016/j.ijrobp.2011.02.052
- ICRU Report 62 (1999). International Commision on Radiation Units and Measurements:Prescribing, recording and reporting photon beam therapy, Bethesda.
- Lara PN Jr, Chansky K, Shibata T, et al (2010). Common arm comparative outcomes analysis of phase 3 trials of cisplatin+irinotecan versus cisplatin+etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology Group 0124. Cancer, 116, 5710-5. https://doi.org/10.1002/cncr.25532
- Maguire P, Sibley G, Zhou SM, et al (1999). Clinical and dosimetric predictors of radiation-Induced esophageal toxicity. Int J Radiat Oncol Biol Phys, 45, 97-103. https://doi.org/10.1016/S0360-3016(99)00163-7
- Patel AB, Edelman MJ, Kwok Y, Krasna MJ, Suntharalingam M (2004). Predictors of acute esophagitis in patients with non small cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int J Radiat Oncol Biol Phys, 60, 1106-12. https://doi.org/10.1016/j.ijrobp.2004.04.051
- Qiao WB, Zhao YH, Zhao YB, Wang RZ (2005) Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity. World J Gastroenterol, 11, 2626-9. https://doi.org/10.3748/wjg.v11.i17.2626
- Rodriguez N, Algara M, Foro P, et al (2009). Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys, 73, 810-7. https://doi.org/10.1016/j.ijrobp.2008.04.064
- Rose J, Rodrigues G, Yaremko B, Lock M, D'Souza D (2009). Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol, 91, 282-7. https://doi.org/10.1016/j.radonc.2008.09.010
- Singh AK, Lockett MA, Bradley JD (2003). Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys, 55, 337-41. https://doi.org/10.1016/S0360-3016(02)03937-8
- Soo RA, Kawaguchi T, Loh M, et al (2012). Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy. Future Oncol, 8, 451-62. https://doi.org/10.2217/fon.12.25
- Takeda K, Nemoto K, Saito H, et al (2005). Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys, 62, 626-9. https://doi.org/10.1016/j.ijrobp.2005.04.004
- Werner-Wasik M, Scott C, Graham ML, et al (1999). Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients. Int J Radiat Oncol Biol Phys, 44, 327-31. https://doi.org/10.1016/S0360-3016(99)00031-0
- Werner-Wasik M, Pequignot E, Leeper D, Hauck W, Curan W (2000). Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys, 48, 689-96. https://doi.org/10.1016/S0360-3016(00)00699-4
- Werner-Wasik M, Yorke E, Deasy J, Nam J, Marks LB (2010). Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys ,76, 86. https://doi.org/10.1016/j.ijrobp.2009.05.070
Cited by
- Oral Glutamine Supplementation Reduces Radiotherapy-induced Esophagitis in Lung Cancer Patients vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.53
- Predictors for severe acute esophagitis in lung cancer patients treated with chemoradiotherapy: a systematic review vol.32, pp.10, 2016, https://doi.org/10.1080/03007995.2016.1205004